Sign in

CIK 0000946644

  • Non-accelerated filer
  • Smaller reporting company

AIM ImmunoTech Inc.

Sign in to watch
Ticker
AIM
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
520845822
Phone
+1 352-448-7797
Business address
2117 SW HIGHWAY 484, OCALA, FL, 32801
Former names
AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
  1. 4 Open-market buy CEO bought 25,000 shares at $0.18 ($4,550)
  2. 4 Open-market buy CEO bought 25,000 shares at $0.18 ($4,538)
  3. 4 Open-market buy CFO, Pres.,Sec., Vice Chairman bought 79,104 shares at an average $0.18 ($14,240)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Open-market buy CEO bought 100,000 shares at $0.24 ($24,200)
  7. 4 Open-market buy CFO, Vice Chairman, Secretary bought 100,000 shares at $0.24 ($24,430)
  8. 4 Open-market buy CEO bought 100,000 shares at $0.24 ($24,000)
  9. 4 Open-market buy CFO, Vice Chairman, Secretary bought 100,000 shares at $0.24 ($23,910)
  10. 4 Open-market buy CEO bought 73,681 shares at $0.23 ($16,947)
  11. 4 Open-market buy CEO bought 26,319 shares at $0.23 ($6,053)
  12. 4 Open-market buy CFO, Vice Chairman, Secretary bought 100,000 shares at $0.23 ($22,540)
  13. 4 Gift Director gave 50,663 shares (gift)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 20 of 31 · 616 filings